Applied Clinical Trials
Current trends in oncology trial terminations as analyzed by Citeline have revealed that sponsors are learning from the past and making gains in this troubled area of drug development.
Christine Blazynski, Ph.D.
Advertisement
Senior Vice-President, Product Development Citeline
Articles by Christine Blazynski, Ph.D.
Advertisement
Latest Updated Articles
Trends in Oncology Trial Terminations: Industry Lessons LearnedAugust 23rd 2012
- Hidden Successes of Oncology Trial Terminations
October 1st 2012
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
2
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
3
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
4
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
5